Most children who have cancer live in the developing world where their survival rate is less than 25%. In Kenya awareness about childhood cancer is low and treatment isn't always readily available.
Nanoparticles are a form of transport for drugs and can go places drugs wouldn't be able to go on their own. They make drug delivery more targeted, reducing collateral damage to healthy tissues.
Better technology to diagnose, treat and manage the disease early enough is needed to improve the survival rates of childhood cancer in sub Saharan Africa.
Children's cancer is a rare disease, which means the market is small and pharmaceutical companies have few incentives to develop drugs for these cancers.
If you’re an Australian teenager or young adult diagnosed with cancer, there’s good news: overall survival rates are good and getting better. But what can you expect from life after cancer treatment?
One in ten cancer patients will face fertility issues after treatment, but less than 50% are given options to preserve fertility. And those who are offered options can face significant cost barriers.
Harsh tales of mothers and fathers thrust into the court system as they seek the best treatment for a sick child are a warning.
Childhood deaths from cancer have decreased by nearly 40% in the past 15 years in Australia. But some types of childhood cancer have shown little improvement.
Early intervention in neurocognition and communication can address communication and cognition difficulties in survivors of childhood brain cancer and increase their quality of life.